ArticlePDF Available

Effects of topical Kiwifruit on healing of neuropathic diabetic foot ulcer

Authors:

Abstract and Figures

Background: Kiwifruit (Actindia Deliciosa) is demonstrated to have antibacterial and pro-angiogenic effects. It also contains proteolytic enzymes (actinidin) and ascorbic acid. In this study, the effects of Kiwifruit on neuropathic diabetic foot ulcer healing in clinical settings were evaluated. Materials and Methods: In this randomized clinical trial of 37 patients (17 in experimental and 20 in control groups) with neuropathic diabetic foot ulcer were studied in Isfahan-Iran. Patients of the control group received just the standard treatments. In the experimental group, in addition to the standard treatments, ulcers were dressed with pure extract of kiwifruit twice daily for 21 days. The ulcers were examined and evaluated based on macroscopic, microscopic and microbiological status. Pre- and post-interventions, biopsies were taken from the ulcers to perform microbiological and histological studies. Results: Mean reduction in surface area of foot ulcer in the experimental group was significantly higher than the control group (168.11 ± 22.31 vs. 88.80 ± 12.04 mm2 respectively, P < 0.0001). The amount of collagen and granulation tissues was significantly higher in the experimental groups than the control group (P value < 0.0001). Significantly higher levels of angiogenesis and vascularization were found in the kiwifruit treated patients (P value < 0.0001). No significant antibacterial effect was observed for kiwifruit. Conclusion: Natural compounds in the kiwifruit including protein-dissolving enzymes (Actinidin) improved different aspects of the wound healing process. Based on these benefits and safety aspects, we conclude that using kiwifruit is a simple, applicable and effective way for treatment of neuropathic diabetic foot ulcer.
Content may be subject to copyright.
ORIGINAL ARTICLE
Effects of Topical Kiwifruit on Healing of Chronic Bedsore
Gholamreza Mohajeri &Masoumeh Safaee &
Mohamad Hossein Sanei
Received: 21 May 2012 /Accepted: 17 January 2013 / Published online: 31 January 2013
#Association of Surgeons of India 2013
Abstract Kiwifruit (Actindia deliciosa) is demonstrated to
have antibacterial and pro-angiogenic effect. Moreover, this
fruit contains proteolytic enzymes (actinidin) and ascorbic
acid. Considering these properties and based on the results
of recent animal studies, we carried out this study to evalu-
ate the effects of kiwifruit on bedsore in clinical settings.
Forty patients with stage 23 sacral bedsores, preferably
paraplegic, quadriplegic, and/or hemiplegic, were allocated
into two groups of experiment and control. Under local
anesthesia and sedation, ulcers of the experiment and con-
trol groups were dressed with pure extract of kiwifruit and
normal saline, respectively, on a daily basis for 21 days. The
ulcers were examined and photographed weekly. Pre- and
postintervention biopsies were taken from the ulcers to
perform microbiological and histological study. Mean re-
duction in surface area of bedsore in the experiment group
was significantly higher than the control group (486.47 vs.
117.38 mm, p<0.001). The amount of collagen and granu-
lation tissue were significantly higher in experiment groups
than the control group (pvalue 0.005 and 0.02, respective-
ly). Significantly higher levels of angiogenesis and vascu-
larizationwerefoundinthekiwifruit-treated patients
(p<0.02). In addition, obvious antibacterial effect was ob-
served in the kiwifruit group. Natural compounds in the
kiwifruit, including protein-dissolving enzymes (actinidin)
and antibacterial agents, improve different aspects of the
wound healing process. Based on its benefits and safety,
we conclude that using kiwifruit is a simple, applicable, and
effective way for treatment of bedsore.
Keywords Kiwifruit .Bedsore .Wound healing
Introduction
Pressure ulcer is a pretty debilitating and common problem
that affects disabled elderly patients. The incidence varies in
different institutions; for instance, recent studies on bedrid-
den patients estimated it to be 3.97.1 % in hospitalized
patients, 4.313.9 % in nursing home residents [14], and
up to 39 % in those with spinal cord injuries [5]. Patients of
intensive care units have the highest rate of this sort of ulcer
[4]. Pressure ulcers can result in enormous expenditures for
patients, as well as for medical centers, and also produce
pain, loss of economic productivity, significant infirmity,
and high mortality rate [6,7].
Prompt identification and intervention are fundamental for
successful treatment of chronic wounds. The focus of wound
bed preparation should be on providing a moist environment,
in addition to accelerated granulation tissue formation, angio-
genesis, and reduced bacterial load in the ulcer.
More than 80 % of the worlds population rely on tradi-
tional medicine including plant-based products for treatment
of various skin problems, especially wound infections and
ulcers [8]. The explanation of the concept of topical medic-
inal herbs is ascribed to Avicenna, the Persian physician and
scholar (9801037 AD)[9].
It is currently accepted that kiwifruit contains potent
protein-dissolving enzymes (actinidin) and antibacterial
agents that could play an important role in wound healing
process. Based on several in vitro and animal studies, the
kiwifruit has proven effects in ulcer debridement, angiogen-
esis, and disinfection; moreover, it has dramatic effects on
healing process of burn wounds [9,10]. Given the above,
G. Mohajeri :M. Safaee (*):M. H. Sanei
Department of Thoracic Surgery, Al-Zahra Hospital,
Isfahan University of Medical Sciences,
Shohaday e Soffeh St, Isfahan, Iran
e-mail: safaee.masumeh@yahoo.com
Indian J Surg (December 2015) 77(Suppl 2):S442S446
DOI 10.1007/s12262-013-0869-5
this study was purposed to investigate the effectiveness of
fresh kiwifruit dressing on treatment of pressure ulcers.
Materials and Methods
In a randomized clinical trial study, by maintaining the respec-
tive rules of research ethical and investigative committee of
the hospital, 40 patients with pressure ulcer at stages 2 or 3
(Table 1) were divided randomly in two groups (groups K and
C). Patients of neither group had obvious finding of underly-
ing osteomyelitis, radiologically and clinically. Routine low-
pressure air mattress was used for all bed-bound patients.
Albumin levels were taken to ensure proper nutrition in each
case. At first, mandatory wound bed preparation such as
removal of nonviable tissue and drainage of abscess was done
for patients who need emergent intervention. The wounds
were anesthetized by local lidocaine 1 %, accompanied by
sedation with ketamine hydrochloride under sterile condition,
and the first specimen from wound place for primary culture
and histological studies was taken, upon arrival, to determine
initial size of the wound. All samples were photographed.
Wound of all patients were kept in environment of the hospital
under study and had sterile dressing.
Twenty-four hours later, wounds were irrigated with sterile
normal saline in all groups. The ulcers were covered with
prepared kiwifruit, in group K. Pure extract of fresh kiwifruit
after being completely mashed by a mixer was poured in
gavage syringe of 50 cc at bedside, and it was placed on the
whole surface of the wound with 3-mm thickness. In group C,
the wounds were dressed with Vaseline sterile gauze without
using any additional agents. In both groups, ulcers were
covered with sterile gauze, which were affixed to skin with
Omnifix (Braun, Melsungen, Germany), a latex-free, nonwo-
ven retention tape. Maintaining sterility, dressings were
changed twice daily in both groups following irrigation with
sterile normal saline. Macroscopically, wound evaluation was
performed every day with digital camera for up to 3 weeks. In
day 21, wound biopsy and culture were obtained under sterile
condition following administration of local anesthesia to the
wounds to be sent after photography for culturing and histo-
pathology was performed. The surface of the ulcers was
measured on the grid-scored digital photos by Sigma Scan
PRO® version 5.0 computer software.
The specimens were stained with hematoxylin and eosin
(H&E), Masson (collagen marker), and CD31 immunohis-
tochemistry (IHC) marker, and one pathologist who is
blinded to the experiment groups accomplished pathological
investigation under Olympus optical microscope. In terms
of pathological survey, parameters such as epithelialization,
inflammation, granulation, collagen synthesis, and vascular-
ization (angiogenesis) were investigated with the following
Table 1 Macroscopic and
microscopic changes
a
Data presented as mean ± SD
b
Data presented as mean rank
c
Data presented as percentage
Case Control pvalue
Day 0 Day 21 Day 0 Day 21
Wound Surface
(mm
2
)
a
866.24±181.18 379.77 ±93.50 737.58 ± 139.94 620.19± 121.36 <0.0001
Epithelializtion
b
0.72 0.72 0 0 1
Vascularization
b
0.22 1.8 0 0.75 0.001
Collagen formation
b
0.42 2.1 0.33 0.60 <0.0001
Inflammation
b
2.27 2.11 1.75 0.92 0.001
Granulation
b
0.11 1.83 0 0.50 0.001
Percentage positive
wound culture
c
72 % 44 % 83 % 67 % 0.17
Fig. 1 Progress of wound
healing in a patient treated with
kiwifruit
Indian J Surg (December 2015) 77(Suppl 2):S442S446 S443
scoring system: 0, none; 1, minimal; 2, mild; 3, moderate;
and 4, maximum.
Streptococcus,Staphylococcus aureus,Staphylococcus
coagulase negative, and Pseudomonas aeruginosa were
the organisms investigated in the cultures that were taken
from the ulcers. The data of all groups were evaluated by
SPSS software V.16. All data were analyzed by the Krus-
kalWallis test, MannWhitney test, and Chi-square tests. A
p<0.05 was considered as statistically significant.
Results
Forty patients with pressure ulcers were enrolled in a random-
ized clinical study. Macroscopic and microscopic changes are
summarized in Table 1. Significant wound healing activity
was observed in patients treated with the kiwifruit compared
with those who received the reference standard treatments.
Macroscopic Findings
1. Woun d a re a : Applying kiwifruit extract significantly
accelerated scar detachment in the experiment group.
The scars detached spontaneously from the wound beds
in B2 group patients later than day 21, whereas this
happened before day 21 in the experiment group.
Measurement of wound area showed significant reduction
in wound size of group B1 as compared with that of group
B2 in the first and 21st days of the experiment (p<0.006)
(Fig. 1).
2. Down stage of the wound: Evaluation of wound stage
showed significant reduction in group B1 as compared
with B2 in the first and 21st days of the experiment
(p<0.049).
3. Macroscopic hyperemia and edema: In group B1, mac-
roscopic hyperemia and edema levels were higher on
days 3 and 5 in comparison to the corresponding control
groups. However, between days 11 and 20, the level
was significantly lower than that of the control group
(p<0.05).
Microscopic Findings
The results of histological scoring of the patients at the end
of the third week and its comparison with the values at the
beginning of the experiment are shown in Table 1, and the
histopathological samples are presented in Figs. 2and 3.
1. Epithelialization: Because most patients with bedsore
had stages 2 and 3 lesions, even after 21 days, only
16.3 % of patients with stage 2 bedsore recovered to
stage 1, and epithelialization was observed (p<0.3).
Fig. 2 Histopathology sample of a patient treated with kiwifruit. a
Section showing low density of inflammatory cell in the dermis and
increased collagen bundles (H&E). bModerate-density vascular
formation in dermis (IHC staining with CD31). cModerate collagen
bundle deposition in the dermis (Masson trichrome staining)
Fig. 3 Histopathology sample
of a patient of the control group.
aSection showing loose dermis
collagen bundle associated with
inflammatory cells (Masson
trichrome staining). bLow
density of vascular structure
(IHC staining with CD31)
S444 Indian J Surg (December 2015) 77(Suppl 2):S442S446
2. Granulation score: The granulation score was higher in
groups B1 compared with group B2, and the difference
was statistically significant (p< 0.02).
3. Inflammation score: In group B1, the number of inflam-
matory cells was lower than that in group B2, but the
difference was not statistically significant (p<1).
4. Collagen formation: The amount of collagen in group
B1 was found to be significantly more than that in group
B2 (p<0.005).
5. Angiogenesis: Vascularization score in group B1 was
found to be significantly higher than that in group
B2 (p<0.02).
Microbiological Findings
Significant antibacterial activity was observed in patient
treated with the kiwifruit (B1) compared with control group
(B2). The difference was statistically significant (p<0.001).
Microscopic evaluation of wounds for blood vessel count
and wound-base collagen deposition revealed significant dif-
ference between the two groups. The number of patient with
ischemic ulcers (such as those with Burgers disease) was not
enough for statistical evaluation. Nevertheless, it was observed
that, compared with the experiment group, scar tissue in these
patients required a longer time for autolysis detachment.
Discussion
The history of using herbal dissolving enzymes for chemical
wound debridement dates back to World War II [11]. Sci-
entists try to investigate the effectiveness of herbal products,
which have been used in Asia and Africa for centuries, in
the treatment of different types of wound [12]. Pressure
wound is one of these sorts of wound. Bedsore is a common,
costly, and debilitating type of wound that usually afflicts
people with advanced age, physical or cognitive disability,
or multiple health problems [13]. Based on the suggested
safety and efficacy for application of kiwifruit wound dress-
inginpreviousanimalstudy[14], we investigated this
method on human cases with bedsore and found it a useful
method. Previous studies have reported various clinical
effects for kiwifruit, such as debridement of dead tissue
and antibacterial effect [10,15].
This was confirmed in our study: kiwifruit extract accel-
erated scar detachment significantly. This effect may be
attributed to some ingredients of kiwifruit including ascor-
bic acid that works as an scavenger, and a strong protein-
dissolving enzyme called actinidin [10,15]. Actinidin is one
kind of cysteine proteases (CPs) found in kiwifruit, which is
responsible for the well known proteolytic and meat-
tenderizing effect of kiwi [14,16]. These substances make
kiwifruit a good option for herbal debridement.
Supporting previous studies, in this study, kiwifruit
showed significant antibacterial properties [10,14]. It may
be related to the composing ingredients of kiwifruit. High
concentration of CPs in many fruits such as kiwi is believed
to have antibacterial, antifungal, and even anti-insect role
[10,16]. In vitro studies reported the antibacterial activity of
18 fractions of kiwifruit extracts against gram-positive and
gram-negative bacteria, and fungi [10,17]. Because wound
infection is a common problem in patients with bedsore,
especially those with fecal incontinence, kiwifruit dressing
can be helpful regarding infection control.
Better vascularization, found in pressure wounds dressed by
kiwifruit, is similar to animal findings [14]. Although angio-
genic compounds are found in several plants such as Aloe vera,
they have not been reported in kiwifruit [18]. Hence, it is
thought that kiwifruit may be rich in some sorts of angiogen-
esis modulators that are essential for the healing process [14].
In addition to macroscopic improvement, histologic evalu-
ation of wounds showed that kiwifruit dressing significantly
increases granulation score and collagen formation. Given
these positive effects, it is not surprising to find significantly
reduced wound surface, as well as improved wound sage, in
kiwifruit-treated bedsores.
A major concern in the treatment with herbal medications
is unknown side effects including allergic reactions. Fortu-
nately, similar to the previous experience on rats [14], no
significant anaphylactic reaction was seen in patients treated
with kiwifruit.
In light of the useful characteristics of kiwifruit including
debridement of devitalized tissuewithout detrimental
effects on the healing processangiogenesis, and antibac-
terial effect, we can conclude that this method is a simple,
applicable, and effective way for the treatment of bedsore.
References
1. Lahmann NA, Kottner J, Dassen T, Tannen A (2012) Higher pressure
ulcer risk on intensive care?comparison between general wards
and intensive care units. J Clin Nurs 21(21385258):35461
2. Kottner J, Dassen T, Lahmann N (2010) Prevalence of deep tissue
injuries in hospitals and nursing homes: two cross-sectional studies.
Int J Nurs Stud 47(19962700):66570
3. Lahmann NA, Halfens RJ, Dassen T (2006) Pressure ulcers in
German nursing homes and acute care hospitals: prevalence, fre-
quency, and ulcer characteristics. Ostomy Wound Manag 52
(16464992):2033
4. Manzano FNM, Roldán D, Moral MA, Leyva I, Guerrero C,
Sanchez MA, Colmenero M, Fernández-Mondejar E, Granada
UPP Group (2010) Pressure ulcer incidence and risk factors in
ventilated intensive care patients. J Crit Care 25(3):46976
5. Gelis A, Dupeyron A, Legros P, Benaim C, Pelissier J, Fattal C
(2009) Pressure ulcer risk factors in persons with spinal cord injury
part 2: the chronic stage. Spinal Cord 47(19350047):65161
6. Landi F, Russo A, Pahor M, Capoluongo E, Liperoti R, Cesari M
et al (2008) Serum high-density lipoprotein cholesterol levels and
Indian J Surg (December 2015) 77(Suppl 2):S442S446 S445
mortality in frail, community-living elderly. Gerontology 54
(18025809):718
7. Brem H, Lyder C (2004) Protocol for the successful treatment of
pressure ulcers. Am J Surg 188(15223496):917
8. Priya KS, Gnanamani A, Radhakrishnan N, Babu M (2002) Heal-
ing potential of Datura alba on burn wounds in albino rats. J
Ethnopharmacol 83:1939
9. Mohajeri G, Masoudpour H, Heidarpour M, Khademi EF,
Ghafghazi S, Adibi S et al (2010) The effect of dressing with fresh
kiwifruit on burn wound healing. Surgery 148(20381106):963
8
10. Basile A, Vuotto ML, Violante U, Sorbo S, Martone G, Castaldo-
Cobianchi R (1997) Antibacterial activity in Actinidia chinensis,
Feijoa sellowiana and Aberia caffra. Int J Antimicrob Agents 8
(18611802):199203
11. Klasen HJ (2000) A review on the nonoperative removal of ne-
crotic tissue from burn wounds. Burns 26(10741585):20722
12. Maenthaisong R, Chaiyakunapruk N, Niruntraporn S, Kongkaew
C (2007) The efficacy of aloe vera used for burn wound healing: a
systematic review. Burns 33(17499928):7138
13. White-Chu EF, Flock P, Struck B, Aronson L (2011) Pressure
ulcers in long-term care. Clin Geriatr Med 27(2):24158
14. Hafezi F, Rad HE, Naghibzadeh B, Nouhi A, Naghibzadeh G (2010)
The effect of dressing with fresh kiwifruit on burn wound healing
Actinidia deliciosa (kiwifruit), a new drug for enzymatic debridement
of acute burn wounds. Burns 36(20101018):3525, Electronic
15. Low CWC, Thomas L, Ramos E, Panarese A, Clarke R et al
(2004) The efficacy of fruit juices in disimpacting meat bolus
obstruction. Otolaryngol Head Neck Surg 131:166
16. Nieuwenhuizen NJ, Maddumage R, Tsang GK, Fraser LG, Cooney
JM, De Silva HN, Green S, Richardson KA, Atkinson RG (2012)
Mapping, complementation, and targets of the cysteine protease acti-
nidin in kiwifruit. Plant Physiol 158(20120103):37688, Electronic
17. Motohashi N, Shirataki Y, Kawase M, Tani S, Sakagami H, Satoh
K et al (2002) Cancer prevention and therapy with kiwifruit in
Chinese folklore medicine: a study of kiwifruit extracts. J Ethno-
pharmacol 81(12127237):35764
18. Fan T-P, Yeh J-C, Leung KW, Yue PYK, Wong RNS (2006)
Angiogenesis: from plants to blood vessels. Trends Pharmacol
Sci 27(16697473):297309
S446 Indian J Surg (December 2015) 77(Suppl 2):S442S446
... Some studies noted no significant difference in ulcer parameters between treatment and routine care groups, [38][39][40][41][42][43][44][45][46] while others reported the promising effects of herbal preparations on treating DFU. [47][48][49][50][51][52][53][54][55][56][57][58] Considering the worldwide use of herbal medicines for DFU management, a critical appraisal of studies performed in different regions is needed to provide more valid evidence for contemporary and future practice and guide future studies on medicinal herbs for DFU. Hence, the present review aimed to comprehensively identify and qualitatively synthesize all recent RCTs, without restricting the country of origin, regarding the effect of topical application and oral intake of herbal products on DFU healing. ...
... Nineteen trials documented the US before and after treatment with a topical product (n = 15) or an oral supplement (n = 4). 38,39,41,43,[48][49][50][52][53][54][55][56][57][65][66][67][68][69][70] Additionally, one RCT noted the effect of an SHF in oral and topical administration routes. 58 Hence, 16 and 5 ESs were obtained for topical and oral intake, respectively. ...
... 58 Hence, 16 and 5 ESs were obtained for topical and oral intake, respectively. Of these, two RCTs that used a topical form of Kiwi fruit were eligible for pooled analysis 49,55 ; however, since there was heterogeneity in the administered form (cream vs. extract), a quantitative analysis was not performed. ...
Article
Full-text available
This systematic review aimed to qualitatively synthesize recent randomized controlled trials (RCTs) regarding the effect of topical application and oral intake of herbal products on the healing of diabetic foot ulcer (DFU). Also, we sought to pool the obtained findings in a meta-analysis using a random-effects model, if RCTs were relatively comparable and homogenous. A comprehensive search was performed on five electronic data sources from their inception through 23 January 2024. The RCTs, without restriction on the country of origin, were included if they compared the effect of administering standard treatments and/or placebo (i.e. control condition) to applying standard treatments and/or herbal products in topical or oral routes (i.e. experimental condition). Out of 1166 retrieved records, 28 RCTs were included. Studies used different poly and single herbal formulations. Based on the meta-analysis, administration of standard care plus daily dressing of the ulcer site with olive oil for 28 days significantly increased the total ulcer healing score (3 RCTs; weighted mean difference [WMD] = 89.30; p < 0.001), raised frequency of complete ulcer healing (2 RCTs; risk ratio [RR] = 12.44; p = 0.039) and declined ulcer degree (3 RCTs; WMD = �22.28; p = 0.002). Also, daily use of the bitter melon leaf extract in oral form for 28 days significantly increased the total ulcer healing score (2 RCTs; WMD = 0.40; p = 0.001). Additionally, based on qualitative synthesis, the adjuvant use of herbal agents seems an intriguing choice to manage DFU. Nonetheless, considering the undesirable methodological quality of most studies and the high heterogeneity in administered herbal formulations, more robust trials are required to build a solid conclusion regarding the use of herbal products for healing DFU. KEYWORDS: diabetic foot, meta-analysis, phytotherapy, plant extracts, wound healing Key Messages • This review aimed to qualitatively and quantitatively synthesize available randomized controlled trials addressing the efficacy of topical and oral administrations of herbal products in the healing of diabetic foot ulcer (DFU). • Based on the quantitative analysis, topical olive oil significantly reduced ulcer degree, as well as raised the total ulcer healing score and frequency of complete ulcer healing. Also, patients supplemented with oral bitter melon leaf extract had substantially higher total ulcer healing scores. • Based on qualitative synthesis, herbal products seem an intriguing choice for healing DFU. Yet, further trials are required to build a solid conclusion.
... Some studies noted no significant difference in ulcer parameters between treatment and routine care groups, [38][39][40][41][42][43][44][45][46] while others reported the promising effects of herbal preparations on treating DFU. [47][48][49][50][51][52][53][54][55][56][57][58] Considering the worldwide use of herbal medicines for DFU management, a critical appraisal of studies performed in different regions is needed to provide more valid evidence for contemporary and future practice and guide future studies on medicinal herbs for DFU. Hence, the present review aimed to comprehensively identify and qualitatively synthesize all recent RCTs, without restricting the country of origin, regarding the effect of topical application and oral intake of herbal products on DFU healing. ...
... Nineteen trials documented the US before and after treatment with a topical product (n = 15) or an oral supplement (n = 4). 38,39,41,43,[48][49][50][52][53][54][55][56][57][65][66][67][68][69][70] Additionally, one RCT noted the effect of an SHF in oral and topical administration routes. 58 Hence, 16 and 5 ESs were obtained for topical and oral intake, respectively. ...
... 58 Hence, 16 and 5 ESs were obtained for topical and oral intake, respectively. Of these, two RCTs that used a topical form of Kiwi fruit were eligible for pooled analysis 49,55 ; however, since there was heterogeneity in the administered form (cream vs. extract), a quantitative analysis was not performed. ...
Article
Full-text available
This systematic review aimed to qualitatively synthesize recent randomized controlled trials (RCTs) regarding the effect of topical application and oral intake of herbal products on the healing of diabetic foot ulcer (DFU). Also, we sought to pool the obtained findings in a meta‐analysis using a random‐effects model, if RCTs were relatively comparable and homogenous. A comprehensive search was performed on five electronic data sources from their inception through 23 January 2024. The RCTs, without restriction on the country of origin, were included if they compared the effect of administering standard treatments and/or placebo (i.e. control condition) to applying standard treatments and/or herbal products in topical or oral routes (i.e. experimental condition). Out of 1166 retrieved records, 28 RCTs were included. Studies used different poly and single herbal formulations. Based on the meta‐analysis, administration of standard care plus daily dressing of the ulcer site with olive oil for 28 days significantly increased the total ulcer healing score (3 RCTs; weighted mean difference [WMD] = 89.30; p < 0.001), raised frequency of complete ulcer healing (2 RCTs; risk ratio [RR] = 12.44; p = 0.039) and declined ulcer degree (3 RCTs; WMD = −22.28; p = 0.002). Also, daily use of the bitter melon leaf extract in oral form for 28 days significantly increased the total ulcer healing score (2 RCTs; WMD = 0.40; p = 0.001). Additionally, based on qualitative synthesis, the adjuvant use of herbal agents seems an intriguing choice to manage DFU. Nonetheless, considering the undesirable methodological quality of most studies and the high heterogeneity in administered herbal formulations, more robust trials are required to build a solid conclusion regarding the use of herbal products for healing DFU.
Article
Full-text available
Diabetes is one of the common endocrine disorders generally characterized by elevated levels of blood sugar. It can originate either from the inability of the pancreas to synthesize insulin, which is considered as an autoimmune disorder, or the reduced production of insulin, considered as insulin resistivity. A wound can be defined as a condition of damage to living tissues including skin, mucous membrane and other organs as well. Wounds get complicated with respect to time based on specific processes like diabetes mellitus, obesity and immunocompromised conditions. Proper growth and functionality of the epidermis gets sustained due to impaired diabetic wound healing which shows a sign of dysregulated wound healing process. In comparison with synthetic medications, phytochemicals like flavonoids, tannins, alkaloids and glycosides have gained enormous importance relying on their distinct potential to heal diabetic wounds. Flavonoids are one of the most promising and important groups of natural compounds which can be used to treat acute as well as chronic wounds. Flavonoids show excellent properties due to the presence of hydroxyl groups in their chemical structure, which makes this class of compounds different from others. Based on the novel principles of nanotechnology via utilizing suitable drug delivery systems, the delivery of bioactive constituents from plant source amplifies the wound-healing mechanism, minimizes complexities and enhances bioavailability. Hence, the encapsulation and applicability of flavonoids with an emphasis on mechanistic route and wound-healing therapeutics have been highlighted in the subsequent study with focus on multiple drug delivery systems. Graphical Abstract
Article
Chronic wounds can be classified as diabetic foot ulcers, pressure ulcers, or venous leg ulcers. Chronic wound management has become a threat to clinicians and constitutes a major healthcare burden. The healing process of chronic wounds requires many factors to work in concert to achieve optimal healing. Various treatment options, ranging from hypoxia to infection, have evolved considerably to address the challenges associated with chronic wound healing. The conventional and accelerating treatments for chronic wounds still represent an unmet medical need due to the complex pathophysiology of the chronic wound microenvironment. In clinical settings, traditional chronic wound care practices rely on nonspecific topical treatment, which can reduce pain and alleviate disease progression with varying levels of success but fail to completely cure the wounds. Conventional wound dressings, such as hydrocolloids, gauze, foams, and films, have also shown limited success for the treatment of chronic wounds and only act as a physical barrier and absorb wound exudates. Emerging advances in treatment approaches, including novel therapies (stem cells, microRNAs, and nanocarrier-based delivery systems) and multifunctional biological dressings, have been reported for chronic wound repair. This review summarizes the challenges offered by chronic wounds and discusses recent advancements in chronic wound treatment.
Article
Full-text available
Background The use of herbal medicines (HMs) for the treatment of hypertension (HTN) is increasing globally, but research on the potential adverse effects and safety of HMs in HTN patients is limited. Therefore, this systematic review and meta-analysis aim to determine the global prevalence of HM usage among HTN patients and assess the safety of identified herbs based on current scientific evidence. Methods The PubMed/MEDLINE, EMBASE (Ovid), and Cumulated Index to Nursing and Allied Health Literature (CINAHL) databases were searched for cross-sectional studies on the use of HM among HTN patients. Our review includes studies published in English up to the year 2023. After extracting and appraising the data from the studies, a meta-analysis was conducted using the Stata version 16.0 to estimate the pooled prevalence of HM use in patients with HTN (PROSPERO: CRD42023405537). The safety classification of the identified HM was done based on the existing scientific literature. Results This study analyzed 37 cross-sectional studies from 21 countries and found that 37.8% of HTN patients used HM to manage their health. The prevalence of HM use varied significantly based on publication year and geographical region. Among the 71 identified herbs, Allium sativum L., Hibiscus sabdariffa L., and Olea europaea L. were the most commonly used. However, four herbs were identified as contraindicated, 50 herbs required caution, and only 11 herbs were considered safe for use. Conclusion The study highlights the potential risks of toxicities and adverse effects associated with HM use in the treatment of HTN. Ensuring patient safety involves using safe HMs in appropriate doses and avoiding contraindicated HMs. Future research should focus on identifying commonly used herbs, especially in resource-limited countries with poor HTN management, and additional clinical research is required to assess the toxicity and safety of commonly used HMs.
Article
Full-text available
Diabetes mellitus is a prevalent cause of mortality worldwide and can lead to several secondary issues, including DWs, which are caused by hyperglycemia, diabetic neuropathy, anemia, and ischemia. Roughly 15% of diabetic patient’s experience complications related to DWs, with 25% at risk of lower limb amputations. A conventional management protocol is currently used for treating diabetic foot syndrome, which involves therapy using various substances, such as bFGF, pDGF, VEGF, EGF, IGF-I, TGF-β, skin substitutes, cytokine stimulators, cytokine inhibitors, MMPs inhibitors, gene and stem cell therapies, ECM, and angiogenesis stimulators. The protocol also includes wound cleaning, laser therapy, antibiotics, skin substitutes, HOTC therapy, and removing dead tissue. It has been observed that treatment with numerous plants and their active constituents, including Globularia Arabica, Rhus coriaria L., Neolamarckia cadamba, Olea europaea, Salvia kronenburgii, Moringa oleifera, Syzygium aromaticum, Combretum molle, and Myrtus communis, has been found to promote wound healing, reduce inflammation, stimulate angiogenesis, and cytokines production, increase growth factors production, promote keratinocyte production, and encourage fibroblast proliferation. These therapies may also reduce the need for amputations. However, there is still limited information on how to prevent and manage DWs, and further research is needed to fully understand the role of alternative treatments in managing complications of DWs. The conventional management protocol for treating diabetic foot syndrome can be expensive and may cause adverse side effects. Alternative therapies, such as medicinal plants and green synthesis of nano-formulations, may provide efficient and affordable treatments for DWs. Graphical abstract
Article
Full-text available
Objectives The choice of the debridement method is very important for the healing of diabetic foot ulcers (DFUs), but the relative effectiveness of different debridement methods in the healing of DFUs remains unclear. This study conducted a network meta-analysis of the relative healing effectiveness of different debridement methods in patients with DFUs. Methods We performed a literature search in PubMed, Embase, and Cochrane Library from database inception up to 30 June 2023 for screening randomized controlled trials on the healing effectiveness of debridement in DFUs. Outcome measures included ulcer healing rate and ulcer area reduction rate. The Cochrane Risk Bias Tool, version 2.0, was used to assess the risk of bias in the included trials. R software was used for performing statistical analysis and GraphPad Prism was used for image plotting. Results A total of 19 randomized controlled trials were included, and 900 patients with DFUs were assessed in this analysis. The proteolytic fraction from the latex of Vasconcellea cundinamarcensis (P1G10) in enzymatic debridement showed the best ulcer healing rate (SURCA = 0.919) when compared with the standard of care (SOC) group, with a mean difference (MD) and 95% confidence interval (CI) of 1.40 (0.57, 2.36). Kiwifruit extract demonstrated the best effect on the ulcer area reduction rate (SURCA = 0.931), when compared with that in the SOC group, with an MD and 95% CI of 0.47 (0.27, 0.66). Conclusion Enzymatic debridement was superior to other debridement methods in terms of ulcer healing rate and ulcer area reduction rate in patients with DFUs. However, as the quality of the included trials is low, enzymatic debridement can be used as a candidate debridement method in addition to sharp-based debridement in clinical practice. Systematic review registration https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023441715.
Article
Full-text available
The use of plants as a source of active principles for cosmetics has significantly increased in the last few years. Safety, compatibility with all types of skin, fewer side effects, and availability are among the advantages of herbal cosmetics above synthetic ingredients. The present review aims to explore the most important plants used in cosmetics. A literature search was carried out in several electronic databases with the following phrases: skincare and plants; cosmetics and plants; natural and cosmetics; and natural and skincare. Furthermore, more detailed filters such as clinical studies, meta-analyses, and systemic reviews were applied to positive results. Various plants and plant extracts currently used in skin care, scaring, whitening, and aging, as well as in sun protection, acne, eczema, and others, have been included in this review. The effectiveness of these plants is based mainly on preclinical research, and to a lesser extent on clinical studies. Some plant extracts or oils have been tested clinically, such as onions, aloe, and tea tree oil, more than other plant extracts. Despite many studies on natural products to improve dermal needs, proper clinical cosmeceutical trials are much fewer than expected. Therefore, more clinical trials are needed to evaluate appropriate efficacy. Furthermore, new formulation technologies might enhance the cosmeceutical benefits, but more work is warranted.
Article
Full-text available
Diabetic Foot Ulcers (DFUs) are a devastating micro-vascular complication of diabetes with an increased prevalence and incidence and high rate of morbidity and mortality. Since antibiotics are frequently used to treat DFU, managing the condition has proven to be extremely challenging and may eventually lead to the development of antibiotic resistance. Scientists from around the world are working to develop an alternative solution to the problem of drug resistance by exploring complementary and alternative medicines that may be obtained from natural sources. Hence, the review aims to comprehensively report the information on the natural treatments and therapy used to manage DFU. All of the information described in the current study was gathered from electronic scientific resources, including Google Scholar, PubMed, Scopus, Science Direct, and Springer Link. Findings from the current review revealed the pre-clinical and clinical utility of 18 medicinal plants, 1 isolated compound, 7 polyherbal formulations including herbal creams, a few micronutrients including vitamins and minerals, insect products such as propolis, honey and, Maggot debridement therapy for the treatment and management of DFU. Natural therapies possess better efficacy, low cost, and shorter duration of treatment when compared with the conventional treatments; hence, all information made available about them is crucial to alter the direction of treatment. Furthermore, the data presented in this review are up to date on the potential efficacy of natural complementary medicines for alleviating DFU problems in in vitro and in vivo tests, as well as clinical studies.
Article
Full-text available
Background and Objective Studies on the influence of low-power laser light on wound healing have shown inconsistent results, or, as in the case of burns, are very scarce. We have studied the effects of two different low-power diode laser lights on the healing of burns in rats.Study Design/Materials and Methods Thirty rats were burned on both flanks and randomly allocated to one of three study groups. In group A, both wounds remained untreated; in groups B and C, one wound each was irradiated with 635 nm or 690 nm laser light (1.5 J/cm2), whereas the other wound remained untreated. Diameter, redness, and edema of the wounds were examined daily.ResultsBetween and within groups, diameter, redness, and edema of the wounds were similar throughout the entire observation period. Irradiation of the burns did not accelerate wound healing when compared with control wounds.Conclusion We conclude that neither 690 nm nor 635 nm low-power laser light produced any beneficial effects on the healing processes of burns in rats. Lasers Surg. Med. 27:39–42, 2000. © 2000 Wiley-Liss, Inc.
Article
Full-text available
Cysteine proteases (CPs) accumulate to high concentration in many fruit, where they are believed to play a role in fungal and insect defense. The fruit of Actinidia species (kiwifruit) exhibit a range of CP activities (e.g. the Actinidia chinensis variety YellowA shows less than 2% of the activity of Actinidia deliciosa variety Hayward). A major quantitative trait locus for CP activity was mapped to linkage group 16 in a segregating population of A. chinensis. This quantitative trait locus colocated with the gene encoding actinidin, the major acidic CP in ripe Hayward fruit encoded by the ACT1A-1 allele. Sequence analysis indicated that the ACT1A locus in the segregating A. chinensis population contained one functional allele (A-2) and three nonfunctional alleles (a-3, a-4, and a-5) each containing a unique frameshift mutation. YellowA kiwifruit contained two further alleles: a-6, which was nonfunctional because of a large insertion, and a-7, which produced an inactive enzyme. Site-directed mutagenesis of the act1a-7 protein revealed a residue that restored CP activity. Expression of the functional ACT1A-1 cDNA in transgenic plants complemented the natural YellowA mutations and partially restored CP activity in fruit. Two consequences of the increase in CP activity were enhanced degradation of gelatin-based jellies in vitro and an increase in the processing of a class IV chitinase in planta. These results provide new insight into key residues required for CP activity and the in vivo protein targets of actinidin.
Article
BACKGROUND: Despite using different treatment modalities, treatment of diabetic foot ulcer is still a very important challenge. In this case series, we report successful treatment of 6 patients with resistant diabetic ulcers using topical application of trichloroacetic acid (TCA). METHODS: Six patients with type 2 diabetes mellitus received standard treatment for 6 weeks. TCA 70% was applied to the periphery of the ulcer while TCA 50% was applied to the center of the ulcer every week until the first significant reepithelialization was observed. RESULTS: All wounds in all 6 treated patients were improved after a mean duration of 7.5 ± 0.83 weeks. In fact, significant reductions were observed in the areas and infection scores of the ulcers. CONCLUSIONS: The range of improvement efficacy ranged from 68.6% to 100% with no complications after 1, 2, and 3 months of follow-up. The observed efficacy of TCA on diabetic ulcer healing is due to production of granulation tissue and epithelial cells.
Article
Problem: Impacted meat bolus in the oesophagus carries an increased risk of morbidity and mortality if it requires retrieval by endoscopic procedures. Certain naturally occurring fruit juices and Coke have been implicated to dissolve meat boluses but without conclusive evidence. This study aimed to ascertain the efficacy of various fruit juices and Coke in dissolving and dislodging meat boluses in vitro.Methods: Eighty 10 mL syringes were modified by removing the tapered ends and pistons. Boiled chicken meat was tightly packed between the 8 mL and 10 mL markers of each syringe. Syringes were positioned vertically with the 10 mL marker above. Two mL each of 8 reagents (fresh pineapple juice (FPJ), frozen-thawed fresh (FTPJ), fresh kiwi juice (FKJ), commercially pasteurized pineapple juice, fresh papaya juice, fresh lemon juice, Coke, and saliva) were poured over the bolus of each syringe, thus dividing them equally into 8 separate groups (n = 10 in each group). Bolus movements were observed over a 23-hour period at 37°C ambient temperature. Movements were noted by recording the upper border of the meat bolus periodically in arbitrary syringe units.Results: At 4 hours and 30 minutes, mean movements (99% CI) for the FPJ, FTPJ, FKJ groups were 3.4 (1.2–5.6), 4.5 (0.9–8.0), and 3.9 (1.1–6.8), respectively. At 23 hours, they were 1.3 (0.6–2.1), 0.3 (0–1.1), and 0.9 (0.5–2.3), with the saliva group (control) being 9.5 (8.9–10.1). The differences in the mean bolus movement between FPJ, FTPJ, FKJ, and saliva were 8.15 (7.1–9.2), 9.15 (8.1–10.2), and 8.55 (7–10.1), respectively. Mann-Whitney U test showed P < 0.001 for all 3 groups. The papaya and Coke groups showed some bolus movement but did not reach statistically significant levels.Conclusion: Fresh pineapple and kiwi fruit juices, which contain proteolytic enzymes bromelain and actinidin respectively, appeared to dissolve chicken boluses effectively. The freezing process for 24 hours preserved Bromelain activity.Significance: Natural pineapple and kiwi fruit juices may be used to disimpact chicken bolus obstruction prior to endoscopic procedures.Support: We wish to thank Mr Bijoux and his team of microbiologist technicians at the Department of Medical Microbiology, Duncan Building 8th floor, University of Liverpool, UK, for their support.
Article
Cited By (since 1996): 13, Export Date: 23 March 2012, Source: Scopus, CODEN: GERND, doi: 10.1159/000111381, PubMed ID: 18025809, Language of Original Document: English, Correspondence Address: Landi, F.; Centro Medicina dell'Invecchiamento (CEMI), Istituto di Medicina Interna e Geriatria, Università Cattolica del Sacro Cuore, Largo Agostino Gemelli 8, IT-00168 Roma, Italy; email: francesco_landi@rm.unicatt.it, Chemicals/CAS: Cholesterol, HDL; Triglycerides, References: Zuliani, G., Romagnoli, F., Bollini, C., Leoci, V., Soattin, L., Fellin, R., Low Levels of high-density lipoprotein cholesterol are a marker of disability in the elderly (1999) Gerontology, 45, pp. 317-322;
Article
Astragali Radix (AR) and Rehmanniae Radix (RR) are two traditional Chinese medicines widely used in China for treating diabetes mellitus and its complications, such as diabetic foot ulcer. In our previous study, a herbal formula NF3 comprising AR and RR in the ratio of 2:1 was found effective in enhancing diabetic wound healing in rats through the actions of tissue regeneration, angiogenesis promotion and inflammation inhibition. The aims of the present study were to investigate the herb-herb interaction (or the possible synergistic effect) between AR and RR in NF3 to promote diabetic wound healing and to identify the principal herb in the formula by evaluating the potencies of individual AR and RR in different mechanistic studies. A chemically induced diabetic foot ulcer rat model was used to examine the wound healing effect of NF3 and its individual herbs AR and RR. For mechanistic studies, murine macrophage cell (RAW 264.7) inflammation, human fibroblast (Hs27) proliferation and human endothelial cell (HMEC-1) migration assays were adopted to investigate the anti-inflammatory, granulation formation and angiogenesis-promoting activities of the herbal extracts, respectively. In the foot ulcer animal model, neither AR nor RR at clinical relevant dose (0.98g/kg) promoted diabetic wound healing. However, when they were used in combination as NF3, synergistic interaction was demonstrated, of which NF3 could significantly reduce the wound area of rats when compared to water group (p<0.01). For anti-inflammation and granulation formation, AR was more effective than RR in inhibiting lipopolysaccharide (LPS)-induced nitric oxide production from RAW 264.7 cells and promoting Hs27 fibroblast proliferation. In the aspect of angiogenesis promotion, only NF3 promoted cell migration of HMEC-1 cells. AR plays a preeminent role in the anti-inflammatory and fibroblast-proliferating activities of NF3. The inclusion of RR, however, is crucial for NF3 to exert its overall wound-healing as well as the underlying angiogenesis-promoting effects. The results of present study justified the combined usage of AR and RR in the ratio of 2:1 as NF3 to treat diabetic foot ulcer and illustrated that AR is the principal herb in this herbal formula.
Article
Successful treatment of infection in the feet of patients with diabetes mellitus remains a challenge. Although the diagnosis of infection remains a clinical decision, presentation in feet rendered insensate from diabetic neuropathy plus co-existing vascular insufficiency means presentation is often atypical. Wounds frequently yield polymicrobial growth and differentiating commensal from pathogenic organisms can be difficult; isolates from diabetic foot wounds are often multidrug resistant. Affected patients often have many other co-morbidities, which not only affect the choice of appropriate antimicrobial regimen but also impede healing. Further, much contention surrounds the management of osteomyelitis, with the merits and role of surgery still undecided. In this review we briefly consider the epidemiology and pathogenesis of diabetic foot disease, before discussing emerging best microbiological practice and how this fits with the multidisciplinary approach required to tackle this difficult clinical problem.